Endpoints News Dec 12, 2025 #SABCS25: Celcuity further details Phase 3 win; Relay’s PI3Kα inhibitor’s consistent performance; and more
FierceBiotech Dec 12, 2025 Cycle seizes struggling Applied Tx, picking up rare disease biotech for pennies per share
FierceBiotech Dec 12, 2025 2026 outlook: Biotech poised to outperform bear markets of ’21-24, analyst says
FierceBiotech Dec 12, 2025 Leading the Way in Biotech Solutions Across Japan and Asia Pacific (JAPAC)
Agilent Dec 12, 2025 Strength in Technology Enabled Products Drives Roper: Can It Sustain? - The Globe and Mail
Endpoints News Dec 12, 2025 Innovent’s obesity drug data in adolescents; Everest gets rights to PCSK9 inhibitor